secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVITA Medical, Inc. (RCEL)
CIK:        0001762303
Form:       8-K
Filed at:   2023-03-02T23:59:59+00:00
Accession:  0001193125-23-058123
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AVITA Medical holds Q4 2022 investor webinar; no new material information disclosed
--------------------------------------------------------------------------------

- Webinar held Feb 28, 2023 with CEO Jim Corbett and acting CFO Sean Ekins.
- Covered highlights from Q4 2022 earnings call; no new financial data provided.
- Slide deck furnished as Exhibit 99.1 but not fully available in this filing.
- No specific financial results, guidance changes, or material events disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523058123/0001193125-23-058123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1762303/000119312523058123/d448380d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-058123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer